Fear of COVID-19 and Physical Activity in Children With Asthma During the Covid Period

NCT05220488 | Completed

• 1 other identifier: COVID-19asthmachildphysicalact
• Study Type: observational
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

Social isolation rules applied to prevent and control COVID-19 disease reduce cross-infection, exposure to more allergens in the home environment, reducing hospital admissions by avoiding contamination, asthma control, fear of COVID-19 and physical activity for reasons such as increased anxiety and lack of exercise. How it will affect is unclear. Considering all these, positive or negative changes in asthma-related risk factors, changes in physical activity level, asthma attacks and control, fear of COVID-19 will be examined and contribute to the literature in children with asthma.

Conditions

Asthma in Children

Keywords

Asthma; COVID-19; Physical Activity

Outcome Measures

Primary Outcomes (1)

• Physical Activity Questionnaire

  It will be evaluated by Physical Activity Questionnaire-Child and Physical Activity Questionnaire-Adolescent. The scale consists of 10 questions and item 10 questions the presence of an illness or an acute condition that limits physical activity. Frequent activities (hopping, walking, football, gymnastics, dance, etc.), level of participation in physical education class, and frequency of activities during break time, lunch time, after school, evening hours and weekends, during leisure time in the last seven days The frequency of the activities performed and the frequency of sports, dance, games and other similar physical activities seven days a week are questioned.

  10 minutes

Secondary Outcomes (3)

• Asthma Control Test

  5 minutes

• Fear of COVID-19

  5 minutes

• Social Isolation

  4 weeks

Study Arms (2)

Asthma Group

Asthma Group

Other: Assessment

Healthy Group

Healthy Group

Other: Assessment

Interventions

Assessment OTHER

Parameters such as physical activity and fear of covid will be evaluated in asthmatic and healthy children and adolescents.

Asthma Group; Healthy Group

Eligibility Criteria

• Age: 6 Years - 18 Years
• Sex: all
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Probability Sample

Study Population

Asthmatic and healthy children and adolescents

You may qualify if:

• Having been diagnosed with asthma,
• In addition, not having any chronic disease,
• Volunteering to participate in the study,
• Not having speech and hearing problems,
• Being cooperative,
• Not having mental, neurological, orthopedic, cardiovascular or pulmonary problems that would prevent physical activity,
• Not having any chronic disease for healthy individuals,
• Volunteering to participate in the study,
• Not having speech and hearing problems,
• Being cooperative,
• Not having a mental, neurological, orthopedic, cardiovascular or pulmonary problem that would prevent physical activity,

You may not qualify if:

• The presence of a medical indication that requires complete restriction of physical activity,
• To have had COVID-19 in the last 1 month or to be newly diagnosed with COVID-19,
• Having symptoms of COVID-19 and suspected illness,
• Not having any chronic disease for healthy individuals,
• Volunteering to participate in the study,
• Not having speech and hearing problems,
• Being cooperative,
• Not having a mental, neurological, orthopedic, cardiovascular or pulmonary problem that would prevent physical activity,

Sponsors & Collaborators

• Bartın Unıversity: lead

Study Sites (1)

Bartın University

Bartın, Turkey (Türkiye)

Location

Related Publications (5)

• Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.

  PMID: 32113704 RESULT

• Skevaki C, Karsonova A, Karaulov A, Xie M, Renz H. Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol. 2020 Dec;146(6):1295-1301. doi: 10.1016/j.jaci.2020.09.017. Epub 2020 Sep 28.

  PMID: 33002516 RESULT

• Lovinsky-Desir S, Deshpande DR, De A, Murray L, Stingone JA, Chan A, Patel N, Rai N, DiMango E, Milner J, Kattan M. Asthma among hospitalized patients with COVID-19 and related outcomes. J Allergy Clin Immunol. 2020 Nov;146(5):1027-1034.e4. doi: 10.1016/j.jaci.2020.07.026. Epub 2020 Aug 6.

  PMID: 32771560 RESULT

• Barsoum Z. Pediatric Asthma & Coronavirus (COVID-19)-Clinical Presentation in an Asthmatic Child-Case Report. SN Compr Clin Med. 2020;2(6):700-702. doi: 10.1007/s42399-020-00310-3. Epub 2020 May 19.

  PMID: 32838131 RESULT

• Papadopoulos NG, Custovic A, Deschildre A, Mathioudakis AG, Phipatanakul W, Wong G, Xepapadaki P, Agache I, Bacharier L, Bonini M, Castro-Rodriguez JA, Chen Z, Craig T, Ducharme FM, El-Sayed ZA, Feleszko W, Fiocchi A, Garcia-Marcos L, Gern JE, Goh A, Gomez RM, Hamelmann EH, Hedlin G, Hossny EM, Jartti T, Kalayci O, Kaplan A, Konradsen J, Kuna P, Lau S, Le Souef P, Lemanske RF, Makela MJ, Morais-Almeida M, Murray C, Nagaraju K, Namazova-Baranova L, Garcia AN, Yusuf OM, Pitrez PMC, Pohunek P, Pozo Beltran CF, Roberts GC, Valiulis A, Zar HJ; Pediatric Asthma in Real Life Collaborators. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden. J Allergy Clin Immunol Pract. 2020 Sep;8(8):2592-2599.e3. doi: 10.1016/j.jaip.2020.06.001. Epub 2020 Jun 17.

  PMID: 32561497 RESULT

MeSH Terms

Conditions

Asthma; COVID-19; Motor Activity

Interventions

Restraint, Physical

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Behavior

Intervention Hierarchy (Ancestors)

Behavior Control; Therapeutics; Immobilization; Investigative Techniques

Study Officials

• Şeyma Nur Önal

  Bartın Unıversity

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Lecturer

Study Record Dates

• First Submitted: January 29, 2022
• First Posted: February 2, 2022
• Study Start: February 3, 2022
• Primary Completion: March 20, 2022
• Study Completion: December 12, 2022
• Last Updated: December 13, 2022

Record last verified: 2022-12

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)